SUNREST

Sunrest Lifescience Share Price

₹54.50 -4 (-6.84%)

23 Dec, 2024 06:38

SIP TrendupStart SIP in SUNREST

Start SIP

Performance

  • Low
  • ₹55
  • High
  • ₹55
  • 52 Week Low
  • ₹49
  • 52 Week High
  • ₹79
  • Open Price₹55
  • Previous Close₹59
  • Volume1,600

Investment Returns

  • Over 1 Month + 0.93%
  • Over 3 Month -8.71%
  • Over 6 Month -13.77%
  • Over 1 Year -8.33%
SIP Lightning

Smart Investing Starts Here Start SIP with Sunrest Lifescience for Steady Growth!

Invest Now

Sunrest Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 23
  • P/B Ratio
  • 1.6
  • Average True Range
  • 3.22
  • EPS
  • 0.53
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.46
  • RSI
  • 46.64
  • MFI
  • 47.97

Sunrest Lifescience Financials

Sunrest Lifescience Technicals

EMA & SMA

Current Price
₹54.50
-4 (-6.84%)
pointer
  • stock-down_img
  • Bullish Moving Average 1
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹56.10
  • 50 Day
  • ₹58.63
  • 100 Day
  • ₹61.61
  • 200 Day
  • -

Resistance and Support

54.5 Pivot Speed
  • R3 54.50
  • R2 54.50
  • R1 54.50
  • S1 54.50
  • S2 54.50
  • S3 54.50

What's your outlook on Sunrest Lifescience?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Sunrest Lifescience Ltd has an operating revenue of Rs. 97.96 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 24%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sunrest Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-05-27 Audited Results

Sunrest Lifescience F&O

Sunrest Lifescience Shareholding Pattern

69.91%
24.87%
5.22%

About Sunrest Lifescience

  • NSE Symbol
  • SUNREST
  • BSE Symbol
  • Managing Director
  • Mr. Nikhilkumar Yashvntlal Thakkar
  • ISIN
  • INE0PLZ01012

Similar Stocks to Sunrest Lifescience

Sunrest Lifescience FAQs

Sunrest Lifescience share price is ₹54 As on 23 December, 2024 | 06:24

The Market Cap of Sunrest Lifescience is ₹23.4 Cr As on 23 December, 2024 | 06:24

The P/E ratio of Sunrest Lifescience is As on 23 December, 2024 | 06:24

The PB ratio of Sunrest Lifescience is 1.6 As on 23 December, 2024 | 06:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23